CRANDELL KEITH

Average Profitability
12.68%
Insider Buys Quantity
5
Insider Buys Sum
$25.59M
Insider Sells Quantity
3
Insider Sells Sum
$20.33M

Insider Activity of CRANDELL KEITH

According to the SEC Form 4 filings, CRANDELL KEITH, being in a position of

  1. 10 percent owner at Sana Biotechnology, Inc.,
    оver the last 12 months, has bought 1090909 shares for $6M, and sold 0 shares,
    over all time since 2024-02-08, has bought 1090909 shares for $6M, and sold 0 shares.

The largest purchase of all time was on 2020-12-22 and amounted to 600000 shares of 908 Devices Inc. for $12M.

The largest sale of all time was on 2020-12-07 and amounted to 150000 shares of Twist Bioscience Corporation for $15.51M.

Biography of CRANDELL KEITH

No biography is available at this moment.

2024-02-08PurchaseSana Biotechnology, Inc.
SANA
10 percent owner
1.09M
0.5382%
$5.50$6M+11.36%
2021-08-12SaleTwist Bioscience Corporation
TWST
director
45,000
0.0933%
$107.01$4.82M-48.34%
2020-12-22Purchase908 Devices Inc.
MASS
600,000
3.8866%
$20.00$12M-31.92%
2020-12-07SaleTwist Bioscience Corporation
TWST
150,000
0.2565%
$103.40$15.51M-8.77%
2018-11-02PurchaseTwist Bioscience Corporation
TWST
150,000
0.7818%
$14.00$2.1M+78.29%
2017-12-11PurchaseQuanterix Corporation
QTRX
266,000
0.9634%
$15.00$3.99M-8.33%
2017-11-27SaleQuanterix Corporation
QTRX
25,830
$0$0
2004-03-19PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
10 percent owner
187,500
0.6189%
$8.00$1.5M-10.99%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.